Correction: Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer

During a recent internal review of our previously published work -conducted as part of preparations for the next phase of our research-we identified an unintentional duplication in Figure 9H, specifically in the RKO cell line Transwell and Matrigel panels between the shCYP26A1-1 and shCYP26A1-2 groups.This duplication was due to a clerical error during figure assembly, rather than data repetition or manipulation.In the interest of scientific accuracy and transparency, and out of respect for our readers, we have made the following corrections and provided the associated materials.We confirm that these corrections do not alter the overall conclusions of our study.We apologize for any confusion this clerical error may have caused and greatly appreciate the editor's and readers' understanding.